Catalyst Pharmaceuticals, Inc. (CPRX)

Catalyst Pharmaceuticals Revenue

Catalyst Pharmaceuticals had revenue of $128.70M in the quarter ending September 30, 2024, with 25.33% growth. This brings the company's revenue in the last twelve months to $460.48M, up 32.17% year-over-year. In the year 2023, Catalyst Pharmaceuticals had annual revenue of $398.20M with 85.90% growth.

• Revenue (ttm): $460.48M
• Revenue Growth: +32.17%
• P/S Ratio: 5.63
• Revenue / Employee: $2,757,377
• Employees: 167
• Market Cap: 2.58B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	398.20M	184.00M	85.90%
Dec 31, 2022	214.20M	73.37M	52.10%
Dec 31, 2021	140.83M	21.76M	18.27%
Dec 31, 2020	119.07M	16.77M	16.39%
Dec 31, 2019	102.31M	101.81M	20,361.20%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.